Volume 17, Issue 5, Pages (November 2002)

Slides:



Advertisements
Similar presentations
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Advertisements

Experimental Models of Inflammatory Bowel Diseases
Volume 134, Issue 7, Pages (June 2008)
Volume 25, Issue 2, Pages (August 2006)
Volume 133, Issue 5, Pages (November 2007)
Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer.
Volume 140, Issue 1, Pages e2 (January 2011)
Volume 133, Issue 4, Pages (October 2007)
Volume 143, Issue 5, Pages (November 2012)
Volume 136, Issue 1, Pages (January 2009)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 26, Issue 3, Pages (March 2007)
Volume 124, Issue 5, Pages (May 2003)
B Cells That Produce Immunoglobulin E Mediate Colitis in BALB/c Mice
Volume 31, Issue 2, Pages (August 2009)
Volume 143, Issue 5, Pages e4 (November 2012)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 141, Issue 2, Pages e4 (August 2011)
Volume 137, Issue 6, Pages e2 (December 2009)
Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice  Eran Elinav, Tova Waks, Zelig Eshhar 
Lung Natural Helper Cells Are a Critical Source of Th2 Cell-Type Cytokines in Protease Allergen-Induced Airway Inflammation  Timotheus Y.F. Halim, Ramona H.
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 10, Issue 1, Pages (January 2015)
Volume 17, Issue 6, Pages (December 2002)
Volume 137, Issue 5, Pages e1 (November 2009)
Volume 141, Issue 5, Pages (November 2011)
Volume 142, Issue 2, Pages e2 (February 2012)
Galectin-1 suppresses experimental colitis in mice
Volume 132, Issue 7, Pages (June 2007)
Volume 136, Issue 2, Pages (February 2009)
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
Volume 28, Issue 4, Pages (April 2008)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 135, Issue 6, Pages e7 (December 2008)
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 141, Issue 1, Pages e1 (July 2011)
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 134, Issue 7, Pages (June 2008)
Volume 138, Issue 2, Pages (February 2010)
Volume 42, Issue 4, Pages (April 2015)
Volume 125, Issue 6, Pages (December 2003)
Rapid development of colitis in NSAID-treated IL-10–deficient mice
Volume 125, Issue 6, Pages (December 2003)
Volume 128, Issue 3, Pages (March 2005)
Volume 29, Issue 6, Pages (December 2008)
Volume 19, Issue 6, Pages (December 2003)
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 29, Issue 5, Pages (November 2008)
Volume 42, Issue 2, Pages (February 2015)
Volume 135, Issue 5, Pages e5 (November 2008)
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 121, Issue 6, Pages (December 2001)
Volume 16, Issue 2, Pages (February 2002)
Volume 119, Issue 3, Pages (September 2000)
Volume 33, Issue 4, Pages (October 2010)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 41, Issue 4, Pages (October 2014)
Volume 15, Issue 4, Pages (April 2014)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
Volume 18, Issue 3, Pages (March 2003)
Volume 132, Issue 2, Pages (February 2007)
Volume 121, Issue 4, Pages (October 2001)
Volume 117, Issue 5, Pages (November 1999)
Volume 17, Issue 5, Pages (October 2016)
Volume 28, Issue 5, Pages (May 2008)
Volume 136, Issue 7, Pages (June 2009)
Volume 27, Issue 4, Pages (October 2007)
Volume 25, Issue 3, Pages (September 2006)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Volume 17, Issue 5, Pages 629-638 (November 2002) Oxazolone Colitis, a Th2 Colitis Model Resembling Ulcerative Colitis, Is Mediated by IL- 13-Producing NK-T Cells  Frank Heller, Ivan J Fuss, Edward E Nieuwenhuis, Richard S Blumberg, Warren Strober  Immunity  Volume 17, Issue 5, Pages 629-638 (November 2002) DOI: 10.1016/S1074-7613(02)00453-3

Figure 1 Presensitization before Intrarectal Challenge with Oxazolone Leads to a Chronic Progressive Colitis Weight loss (A) and mortality (B) of mice after presensitization with vehicle (ethanol) or oxazolone and intrarectal challenge with vehicle or different doses of oxazolone. Each study group analyzed contained ≥ ten mice. Data shown represent mean values obtained from three independent experiments. Photomicrograph of an H/E-stained section of colon from a control mouse presensitized and challenged intrarectally with ethanol alone at 7 days after intrarectal challenge, 5× (C) and 10× (E). Photomicrograph of an H/E-stained section of colon from a mouse presensitized with 3% oxazolone and challenged intrarectally with 1% oxazolone at 7 days after intrarectal challenge, 50× (D) and 100× (F). Immunity 2002 17, 629-638DOI: (10.1016/S1074-7613(02)00453-3)

Figure 2 Cytokine Production from Lymphocytes from Mice with Oxazolone Colitis (A) Lamina propria mononuclear cells (LPMC), hepatic mononuclear cells (HMNC), mesenteric lymph node cells (MLNC), and splenocytes (SPC) were isolated on day 5 after induction of oxazolone colitis (stippled) or TNBS colitis (black) and stimulated in vitro for 48 hr with plate-bound anti-CD3 and soluble anti-CD28. Baseline values of LPMC for IL-4 and IL-13 of ethanol-treated mice were nondetectable. The data shown represent the mean values obtained from three independent experiments. All cytokine values obtained with cells from mice with oxazolone colitis were significantly different from cells from mice with TNBS colitis (p ≤ 0.01). (B) LPMC were isolated on days 2, 5, or 8 after induction of oxazolone colitis. LPMC were stimulated as above, and the concentrations of IL-4 (open bars) and IL-13 (striped bars) were measured in the supernatants. The data show IL-4 and IL-13 values on day 8 as compared to day 2 in LPMC; p < 0.01. The data shown represent the mean values obtained from three independent experiments. Immunity 2002 17, 629-638DOI: (10.1016/S1074-7613(02)00453-3)

Figure 3 Neutralization of IL-13 Prevents Induction of Oxazolone Colitis (A) Weight loss and (B) survival in mice presensitized with 1% oxazolone, intrarectally challenged with 1% oxazolone, and then treated with IL13Rα2-Fc or control protein at the time of intrarectal challenge. Each study group analyzed contained ≥ ten mice. The data shown represent the mean values obtained from three independent experiments. Immunity 2002 17, 629-638DOI: (10.1016/S1074-7613(02)00453-3)

Figure 4 Depletion of NK1.1-Positive Cells Protects Mice from Oxazolone Colitis but Not TNBS Colitis Weight loss (A and C) and mortality (B and D) after induction of oxazolone colitis (A and B) or TNBS colitis (C and D) or injection of vehicle (ethanol). Mice were injected with control antibody or depleted of NK1.1 cells with anti-NK1.1 (PK136). Each study group analyzed contained ≥ ten mice. The data shown represent the mean values obtained from three independent experiments. Immunity 2002 17, 629-638DOI: (10.1016/S1074-7613(02)00453-3)

Figure 5 β2m-Deficient Mice Are Resistant to the Development of Oxazolone Colitis β2m-deficient mice (B6/SJL background) and their wild-type littermates (B6/SJL) after induction of oxazolone-colitis. Wild-type mice but not β2m-deficient mice lost weight and had poor survival (A and B). In addition, whereas β2m-deficient mice did not manifest microscopic evidence of inflammation (C), wild-type mice manifested inflammation characterized by epithelial ulceration, inflammatory cell infiltration of the mucosal superficial layers, and edematous bowel wall (D). It should be noted that the level of inflammation developing in these wild-type mice was milder than that observed in Bl10 wild-type mice because the B6/SJL strain is relatively resistant to oxazolone-colitis. Each study group analyzed contained ten mice per group. Immunity 2002 17, 629-638DOI: (10.1016/S1074-7613(02)00453-3)

Figure 6 CD1 Antigen Presentation and Jα281 NK-T Cells Are Essential for Induction of Oxazolone Colitis (A) Weight loss of mice after intrarectal injection of ethanol or oxazolone after i.v. injection of blocking CD1 antibodies (20H2) or control antibody. (B) Weight loss after induction of oxazolone colitis of CD1−/− mice, Jα281−/− mice, and wild-type mice. Each study group analyzed contained ≥ ten mice. Weight loss and/or graded histologic changes were statistically significant for both groups of knockout mice versus wild-type mice (at least a p value ≤ 0.03). Both the CD1−/− and Jα281−/− mice were backcrossed onto the BL/6 background (CD1−/− [N10] and Jα281−/− [N6]). Immunity 2002 17, 629-638DOI: (10.1016/S1074-7613(02)00453-3)

Figure 7 Cytokine Production in Response to αGalCer LPMC (upper panel), splenocytes, or spleen CD4 cells (lower panel) were isolated on day 8 after induction of oxazolone colitis and either stimulated or not stimulated (unstimulated) for 48 hr with plate-bound anti-CD3 and soluble anti-CD28 (αCD3/CD28), untransfected L cells (LCD1) and vehicle (αGalCer Solvent), or CD1 transfected L cells and 100 ng/ml αGalCer (LCD1 and αGC). Each study group analyzed contained ≥ ten mice. The data shown represent the mean values obtained from three independent experiments. IL-13 secretion levels induced by αGalCer in CD4 cells from mice without oxazolone colitis were below the limit of detection. Immunity 2002 17, 629-638DOI: (10.1016/S1074-7613(02)00453-3)